We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+6.04%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$123M
AUM Growth
+$8.68M
(+7.6%)
Cap. Flow
+$4.39M
Cap. Flow
% of AUM
3.58%
Top 10 Holdings %
Top 10 Hldgs %
32.36%
Holding
136
New
12
Increased
36
Reduced
49
Closed
4
Avg Time Held Equity + Options
7.5
quarters
Top 10 Avg Time Held Equity + Options
3.6
quarters
Top 20 Avg Time Held Equity + Options
6
quarters
Avg Time Held Equity only
7.5
quarters
Top 10 Avg Time Held Equity only
3.6
quarters
Top 20 Avg Time Held Equity only
6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Barrick Mining
B
|
+$1.91M |
| 2 |
Procter & Gamble
PG
|
+$1.17M |
| 3 |
Emerson Electric
EMR
|
+$937K |
| 4 |
General Motors
GM
|
+$886K |
| 5 |
BK Technologies
BKTI
|
+$886K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$1.85M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.63M |
| 3 |
SSW.PRC
SEASPAN CORP 9.50% SER C RED PERP PFD SHS (MHL)
SSW.PRC
|
+$1.1M |
| 4 |
Merck
MRK
|
+$329K |
| 5 |
GE Aerospace
GE
|
+$287K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.02% |
| 2 | Real Estate | 16.26% |
| 3 | Healthcare | 13.6% |
| 4 | Technology | 12.17% |
| 5 | Financials | 9.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
CHS Inc 8% Preferred Stock
CHSCP
$317M
| $1.51M | 1.23% |
45,157
-700
| -2% | -$22.5K |
2013 Q2
12 quarters
|
|
27
Apple
AAPL
$4.98T
| $1.43M | 1.16% |
59,648
-4,216
| -7% | -$105K |
2013 Q2
12 quarters
|
|
28
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.42M | 1.16% |
107,100
-2,500
| -2% | -$30.2K |
2013 Q2
12 quarters
|
|
29
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$169M
| $1.27M | 1.04% |
79,922
-3,100
| -4% | -$48.3K |
2014 Q3
7 quarters
|
|
30
Healthpeak Properties
DOC
$13.1B
| $1.25M | 1.02% |
38,924
-1,153
| -3% | -$35.8K |
2013 Q2
12 quarters
|
|
|
31
Procter & Gamble
PG
$355B
| $1.21M | 0.99% |
+14,275
| New | +$1.17M |
2016 Q2
0 quarters
|
|
32
iShares Mortgage Real Estate ETF
REM
$452M
| $1.2M | 0.98% |
29,213
+13,513
| +86% | +$542K |
2013 Q2
12 quarters
|
|
33
Sarepta Therapeutics
SRPT
$1.74B
| $1.19M | 0.97% |
62,150
-7,200
| -10% | -$133K |
2013 Q2
12 quarters
|
|
34
AT&T
T
$157B
| $1.17M | 0.95% |
35,704
+1,009
| +3% | +$30K |
2015 Q2
4 quarters
|
|
|
35
GE Aerospace
GE
$319B
| $1.15M | 0.94% |
7,630
-1,968
| -21% | -$287K |
2013 Q2
12 quarters
|
|
36
Devon Energy
DVN
$55.2B
| $1.14M | 0.93% |
31,403
-2,800
| -8% | -$95K |
2013 Q2
12 quarters
|
|
37
BlackRock Core Bond Trust
BHK
$594M
| $1.09M | 0.89% |
78,254
+200
| +0.3% | +$2.72K |
2014 Q4
6 quarters
|
|
38
Wells Fargo
WFC
$244B
| $1.07M | 0.87% |
22,650
+2,000
| +10% | +$97.5K |
2013 Q2
12 quarters
|
|
|
TRIB
39
Trinity Biotech
TRIB
$5.12M
| $1.03M | 0.84% |
607
+50
| +9% | +$84.5K |
2013 Q2
12 quarters
|
|
40
Goldman Sachs Group Inc Depositary Shares
GS.PRA
$577M
| $977K | 0.8% |
47,369
-600
| -1% | -$12.1K |
2013 Q2
12 quarters
|
|
|
AERI
41
DELISTED
Aerie Pharmaceuticals
AERI
| $963K | 0.79% |
54,700
+4,200
| +8% | +$68K |
2014 Q3
7 quarters
|
|
|
42
Emerson Electric
EMR
$91.2B
| $921K | 0.75% |
+17,648
| New | +$937K |
2016 Q2
0 quarters
|
|
|
43
Merck
MRK
$350B
| $873K | 0.71% |
15,877
-6,178
| -28% | -$329K |
2013 Q2
12 quarters
|
|
|
SSW.PRD
44
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
| $860K | 0.7% |
33,600
+1,300
| +4% | +$32.2K |
2013 Q2
12 quarters
|
|
45
iShares S&P 100 ETF
OEF
$20.8B
| $856K | 0.7% |
9,215
| – | – |
2013 Q2
12 quarters
|
|
46
KKR & Co
KKR
$78.2B
| $852K | 0.69% |
69,081
-3,220
| -4% | -$43.1K |
2014 Q2
8 quarters
|
|
47
Johnson Controls International
JCI
$94.8B
| $821K | 0.67% |
+17,715
| New | +$781K |
2016 Q2
0 quarters
|
|
48
Teva Pharmaceutical Industries Limited
TEVA
$48.1B
| $777K | 0.63% |
15,469
+1,494
| +11% | +$79.5K |
2016 Q1
1 quarter
|
|
49
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $683K | 0.56% |
31,500
-1,500
| -5% | -$30.3K |
2013 Q2
12 quarters
|
|
50
DELISTED
Kennedy-Wilson Holdings
KW
| $664K | 0.54% |
35,000
| – | – |
2013 Q2
12 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q2 2016 Portfolio in Review
As of Q2 2016, Benchmark Capital Advisors held 136 positions worth $123M, up 7.6% from $114M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Benchmark Capital Advisors deployed $4.39M of net new capital in Q2 2016, opening 12 new positions and adding to 36 existing holdings. Its largest new stake was Barrick Mining: 107,500 shares worth $2.29M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, down from 19% a quarter earlier, followed by Real Estate and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $1.63M trimmed.
- Benchmark Capital Advisors's largest Q2 2016 buy was Barrick Mining: 107,500 shares worth $2.29M.
- Benchmark Capital Advisors added most to General Motors in Q2 2016, an estimated $886K increase.
- Benchmark Capital Advisors's biggest Q2 2016 reduction was Meta Platforms (Facebook), cutting an estimated $1.63M.
- Benchmark Capital Advisors fully exited Ventas in Q2 2016, selling an estimated $1.85M.
- Benchmark Capital Advisors's ten largest holdings make up 32% of its $123M portfolio in Q2 2016.
- Benchmark Capital Advisors opened 12 new positions and closed 4 in Q2 2016.
- Benchmark Capital Advisors's portfolio value rose 7.6% quarter-over-quarter to $123M.
Based on Benchmark Capital Advisors's 13F filing for Q2 2016, filed 9 Aug 2016.